Clinical Trials
Retina & Eye Consultants are actively involved in both local and international clinical trials
Retina Consultants are actively involved in both local and international clinical trials.
These studies are important in measuring the outcomes of current treatments and improving patient eye disease management.
MACULA HOLE STUDY
The aim of the study is to present the visual results following macular hole surgery, and also to investigate the clinical course and results (anatomical and visual) of primary idiopathic macular hole eyes where primary surgery failed. Preliminary findings have been published in the May 2016 edition of Ophthalmology American Academy of Ophthalmology.
CONTROL STUDY
The Control study is a 24 month study looking at the role of Lucentis in the treatment of retinal swelling due to diabetic eye disease.
This study is sponsored by Norvatis
RIPPLE STUDY
This trial is a phase II, multi-centre, single-masked, dose-ranging study designed to evaluate the relative safety and primary efficacy of 2 dosage treatments of the IBE-814 IVT Dexamethasone Implant in patients with Diabetic Macular Oedema (DMO) and macular oedema due to Retinal Vein Occlusion (RVO). The study treatment consists of either one or two dexamethasone implants, which is a slow releasing steroid medication. If the participant is eligible, the study lasts for 18 months where there will be a visit 1 week post treatment and then on a monthly basis. The ultimate goal is to decrease retinal swelling and improve vision.
